Cantor Fitzgerald Raises PT for CytomX Therapeutics to $10, Maintains Overweight Rating

miércoles, 4 de febrero de 2026, 11:17 am ET1 min de lectura
CTMX--

Cantor Fitzgerald Raises PT for CytomX Therapeutics to $10, Maintains Overweight Rating

Cantor Fitzgerald Raises PT for CytomX Therapeutics to $10, Maintains Overweight Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios